Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2003
11/06/2003CA2479943A1 Method for reduction of residual organic solvent in carbomer
11/05/2003EP1359152A2 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
11/05/2003EP1358188A2 Antagonists of mcp-1 function and methods of use thereof
11/05/2003EP1358187A2 Naphthyridine derivatives
11/05/2003EP1358185A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
11/05/2003EP1358184A1 Substituted alkylamine derivatives and methods of use
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP0946566B1 Pro-drugs and counterparts of camptothecin, their application as medicines
11/05/2003EP0770064B1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1454083A Selective androgen receptor modulators and methods for their identification design and use
11/05/2003CN1453278A Omprazole compound and its prepn and application
11/04/2003US6642273 Dermatology, vision defects, cardiovascular disorders, antiinflammatory
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642250 1,8-naphthyridin-2(1H)-one derivatives
11/04/2003US6642249 3-Oxo-pyrazolo(4,3-c) -quinolin-2-yl, -thiochroman-2-yl, or -chromen-2-yl derivatives; CD80 antagonists
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642244 Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
11/04/2003US6642230 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
11/04/2003US6642224 Activated blood coagulation factor X inhibitors
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/04/2003US6642180 Biphenyl-substituted cyclic ketoenols as pesticides
11/04/2003US6641840 Sustained release formulations for growth hormone secretagogues
11/04/2003US6641784 Tris-(2,3-epoxypropyl)isocyanurate, is presented. The optical resolver comprises an optically active tris-(epoxyalkyl) isocyanurate or its derivative, or an optically active derivative of a tris-(epoxyalkyl)isocyanurate, High
11/04/2003CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
11/04/2003CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
11/04/2003CA2078517C Process for the preparation of omeprazole
10/2003
10/31/2003WO2002085909A1 9-deazaguanine derivatives as inhibitors of gsk-3
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089416A1 Substituted pyrimidine-2,4(1h,3h)-diones for use as matrix metalloproteinase (mmp) inhibitors
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088968A1 Compounds having unique cb1 receptor binding selectivity and methods for their production and use
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003039545A3 Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and others cancers
10/30/2003WO2003031452A3 4-haloethenylphenyl tropane:serotonin transporter imaging agents
10/30/2003WO2002066476A9 6-phenylbenzonaphthyridines
10/30/2003US20030204090 Administering to a patient an indazoline compound to treat cancer, inflammatory disorder or autoimmune disease
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203916 1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity
10/30/2003US20030203911 5-Arylsulfonyl-imidazo[1',2':1,6]pyrido[2,3-b]pyrazine-6-amines and related compounds
10/30/2003US20030203910 A phenoxy-alkyl-quinoxalinone derivatives for inhibiting drug transport proteins that efflux therapeutic agents from cells; synergistic
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203897 2,4-Disubstituted thiazolyl derivatives
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481940A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/29/2003EP1357124A1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
10/29/2003EP1357114A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP)
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1355909A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/29/2003EP0923566B1 High molecular weight polymer-based prodrugs
10/29/2003CN1452623A 4-phenyl substd. tetrahydroisoquinolines and therapeutic use thereof
10/29/2003CN1452621A Process for preparing substd. imidazopyridine compound
10/29/2003CN1452619A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
10/29/2003CN1452489A Praziquantel composition for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
10/29/2003CN1451660A Process for preparing granisetron and its salt
10/28/2003US6639023 Fluorophenyl resin compounds
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638937 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/28/2003US6638933 Bicyclic imidazo-3-yl-amine derivatives
10/28/2003US6638929 Tricyclic protein kinase inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638925 Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087100A1 Process for preparing acid salts of gemifloxacin
10/23/2003WO2003087099A1 Imidazo-pyridine derivatives as ligands for gaba receptors
10/23/2003WO2003087098A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003087092A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087088A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087086A2 Substituted indoles
10/23/2003WO2003087064A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086467A1 Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor
10/23/2003WO2003086406A1 Imidazo-pyridine derivatives as ligands for gaba receptors
10/23/2003WO2003086403A1 Inhibitors of akt activity
10/23/2003WO2003086400A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
10/23/2003WO2003086395A1 Tyrosine kinase inhibitors
10/23/2003WO2003086394A1 Inhibitors of akt activity
1 ... 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 ... 646